Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days

News

The Lancet2d
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Copyright: © 2015 Elsevier Ltd. Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Charged w/ rape, trafficking
Sentenced for abusing kids
To pardon reality TV stars
Kevin Costner sued
Man grabs gun, shoots self
Boil-water advisory issued
Two agents suspended
Won’t face death penalty
2nd arrest in torture case
Racist fan behavior probe
Violent break-in at CA home
Starship rocket breaks up
Disappointed w/ Trump's bill
Ex-NBA star pleads guilty
DOJ sues NC over voter rolls
RU teams remain banned
Hamas leader killed?
DOGE can access data
Judge blocks Trump order
Iranian man pleads guilty
Sumo has a new champion
MO abortion ban reinstated
Manhattanhenge 2025
Zelenskyy visits Berlin
To cut federal contracts
Machinists end 3-week strike
Judge backs NYC toll plan
NYC HS student detained
Migrant boat capsizes
Jeanine Pirro sworn in
Rock slide hits Swiss village
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy